Research library

Compound comparisons

Some compounds are so often discussed together — or confused with each other — that the clearest way to present the research is side by side. Every fact on these pages restates the full profiles, which carry the citations; the comparison adds arrangement, never new claims.

BPC-157 vs TB-500
BPC-157 and TB-500 compared as research materials: molecular origin, proposed mechanisms, evidence maturity and UK regulatory status, with cited sources.
Semaglutide vs tirzepatide vs retatrutide
The three incretin-pathway peptides compared as research materials: receptor targets, molecular engineering, evidence maturity and UK regulatory status, with cited sources.
Melanotan I vs Melanotan II
Melanotan I (afamelanotide) and Melanotan II compared as research materials: receptor selectivity, regulatory status and the reasons the two are so often confused, with cited sources.
Selank vs Semax
Selank and Semax compared as research materials: parent sequences, proposed mechanisms, the Russian research context and UK regulatory status, with cited sources.
CJC-1295 vs ipamorelin
CJC-1295 and ipamorelin compared as research materials: two different receptors in the same axis, the combination rationale, and what the evidence does and does not cover, with cited sources.

Compound comparisons

BPC-157 vs TB-500

Semaglutide vs tirzepatide vs retatrutide

Melanotan I vs Melanotan II

Selank vs Semax

CJC-1295 vs ipamorelin